Bacterial infections:

Indications for: REBYOTA

Prevention of recurrence of Clostridioides difficile infection (CDI) in adults following antibiotic treatment for recurrent CDI.

Limitations of Use:

Not for treatment of CDI.

Adult Dosage:

For rectal use only. Empty bladder and bowel before administration. Give a single dose (150mL) 24–72hrs after the last dose of antibiotics for CDI. 

Children Dosage:

<18yrs: not established.

REBYOTA Warnings/Precautions:

Manufactured from human fecal matter. Risk of transmissible infectious agents. Potential presence of food allergens. Acute allergic reactions. Have appropriate medical treatment immediately available. 

REBYOTA Interactions:

Avoid any oral antibiotic therapy for up to 8 weeks after Rebyota administration.

Adverse Reactions:

Abdominal pain, diarrhea, abdominal distention, flatulence, nausea.

Generic Drug Availability:


How Supplied:

Single-dose cartons—6